Seaport Therapeutics, Inc. Common Stock
NASDAQ:SPTXBiotechnology
+$0.10 today
- Market cap
- $980.14M
- Beta
- 0.00
Volume 0.68M
Average 0.41M
SPTX Interest Income
Income earned on cash, deposits, and investments held by the company.
Interest Income history
Currency unavailable · from the income statement
No Interest Income data reported for this period type.
Interest Income vs competitors
How SPTX compares with its peers on the latest reported figures
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
RAPPRapport Therapeutics, Inc. Common Stock | LTM Mar 2026 | $14.93M USD | +11.7% | — | 74.6% |
CTNMContineum Therapeutics, Inc. Class A Common Stock | LTM Mar 2026 | $8.5M USD | -10.7% | +121.3% | — |
| LTM Mar 2026 | $7.18M USD | +62.2% | +134.3% | — | |
LBRXLB Pharmaceuticals Inc Common Stock | LTM Mar 2026 | $6.36M USD | — | +277.3% | — |
NMRANeumora Therapeutics, Inc. Common Stock | LTM Mar 2026 | $6.07M USD | -63.6% | +22.3% | — |
| LTM Mar 2026 | $2.32M USD | -61.0% | +45.2% | — | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
SPTXSeaport Therapeutics, Inc. Common Stock | — | — | — | — | — |
| Peer median (excluding SPTX) | — | -10.7% | +121.3% | 37.3% | |
Competitors are the stored peer set for SPTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Seaport Therapeutics, Inc. Common Stock
NASDAQ:SPTX
Intrinsic Alpha fair value
Locked
Current Price
$18.31
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.